The combination of anti-Fn-IgA, CEA and CA19-9 exhibited highest sensitivity (40.0%) and specificity (94.22%) for early CRC detection with highest PPV (56.4%) and good NPV (89.4%). The gene discussed is FN1; the disease is colorectal carcinoma.